Overview

To Determine Tolerability to Glucagon Infusion in Obese Subjects

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To further understand the tolerability of glucagon.
Phase:
Phase 1
Details
Lead Sponsor:
Translational Research Institute for Metabolism and Diabetes, Florida
Treatments:
Glucagon
Glucagon-Like Peptide 1